Management of the drug overdose patient. Part II. Specific antidotes.
D000931:Antidotes / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000506:poisoning; D003676:Deferoxamine / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000506:poisoning; D000432:Methanol / Q000506:poisoning; D009270:Naloxone / Q000627:therapeutic use; D011041:Poisoning / Q000188:drug therapy*; D011220:Pralidoxime Compounds / Q000627:therapeutic use
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D011220:Pralidoxime Compounds; D009270:Naloxone; D007501:Iron; D003676:Deferoxamine; D000432:Methanol